Baur, Alexander D. J. http://orcid.org/0000-0001-5157-6550
Penzkofer, Tobias
Article History
Received: 7 April 2019
Accepted: 16 April 2019
First Online: 9 May 2019
Compliance with ethical standards
:
: The scientific guarantor of this publication is Alexander D. J. Baur.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.Outside of the current work, Alexander D. J. Baur has received payments as a speaker for Bayer Pharma AG and Uropharm AG and research support from Bayer Pharma AG (no personal payments).Tobias Penzkofer received grant support from the Berlin Institute of Health within the Clinician Scientist Programme and received research support from Siemens Healthcare and Philips Healthcare (no personal payments). Outside of the current work, Tobias Penzkofer is involved in clinical trials with AGO, Aprea AB, Astellas Pharma Global Inc., AstraZeneca, Celgene, Genmab A/S, Incyte Coporation, Lion Biotechnologies, Inc., Millennium Pharmaceuticals, Inc., Morphotec Inc., MSD, Tesaro Inc., and Roche.
: A statement regarding statistics and biometry is not applicable.
: A statement regarding informed consent is not applicable.
: A statement regarding ethical approval is not applicable.
Free to read: This content has been made available to all.